Fig. 8

A working model of TCDCA in GBM cells. TCDCA suppresses the progression of GBM via HMGCS1/HMGCR/GPX4 signaling axis, which may result in inhibiting the tumorigenesis, including inhibition of cell proliferation, migration, and induction of the apoptosis and cell cycle arrest both in vitro and in vivo